Stratec SE (SBS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, Stratec SE (SBS) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.34 Million ≈ $5.07 Million USD) by net assets (€240.08 Million ≈ $280.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Stratec SE - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Stratec SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SBS liabilities breakdown for a breakdown of total debt and financial obligations.

Stratec SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stratec SE ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
The E&M Co. Ltd KQ:089230	-0.093x
Caxton JSE:CAT	0.109x
Deo Ca Traffic Infrastructure Investment JSC VN:HHV	0.009x
Cogelec SA PA:ALLEC	0.282x
Chorokbaem Healthcare Co Ltd KO:118000	0.000x
First United Corporation NASDAQ:FUNC	0.007x
DCX Systems Limited NSE:DCXINDIA	0.002x
Mitrabahtera Segara Sejati Tbk JK:MBSS	49.540x

Annual Cash Flow Conversion Efficiency for Stratec SE (2002–2024)

The table below shows the annual cash flow conversion efficiency of Stratec SE from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see SBS company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€242.53 Million ≈ $283.55 Million	€48.71 Million ≈ $56.95 Million	0.201x	+141.25%
2023-12-31	€233.33 Million ≈ $272.78 Million	€19.43 Million ≈ $22.71 Million	0.083x	+82.38%
2022-12-31	€225.18 Million ≈ $263.26 Million	€10.28 Million ≈ $12.02 Million	0.046x	-85.20%
2021-12-31	€205.76 Million ≈ $240.55 Million	€63.47 Million ≈ $74.21 Million	0.308x	+67.12%
2020-12-31	€172.54 Million ≈ $201.72 Million	€31.85 Million ≈ $37.23 Million	0.185x	+38.04%
2019-12-31	€159.01 Million ≈ $185.90 Million	€21.26 Million ≈ $24.86 Million	0.134x	+70.31%
2018-12-31	€152.20 Million ≈ $177.94 Million	€11.95 Million ≈ $13.97 Million	0.079x	-58.67%
2017-12-31	€157.84 Million ≈ $184.53 Million	€29.98 Million ≈ $35.05 Million	0.190x	+67.93%
2016-12-31	€143.72 Million ≈ $168.02 Million	€16.26 Million ≈ $19.00 Million	0.113x	-43.40%
2015-12-31	€130.28 Million ≈ $152.31 Million	€26.03 Million ≈ $30.44 Million	0.200x	-43.67%
2014-12-31	€112.05 Million ≈ $131.00 Million	€39.75 Million ≈ $46.47 Million	0.355x	+44.63%
2013-12-31	€97.18 Million ≈ $113.61 Million	€23.84 Million ≈ $27.87 Million	0.245x	+729.52%
2012-12-31	€91.98 Million ≈ $107.54 Million	€2.72 Million ≈ $3.18 Million	0.030x	-77.01%
2011-12-31	€83.23 Million ≈ $97.31 Million	€10.71 Million ≈ $12.52 Million	0.129x	+538.58%
2010-12-31	€71.88 Million ≈ $84.03 Million	€1.45 Million ≈ $1.69 Million	0.020x	-89.02%
2009-12-31	€59.29 Million ≈ $69.31 Million	€10.88 Million ≈ $12.72 Million	0.183x	+95.22%
2008-12-31	€49.90 Million ≈ $58.34 Million	€4.69 Million ≈ $5.48 Million	0.094x	-52.28%
2007-12-31	€48.58 Million ≈ $56.79 Million	€9.57 Million ≈ $11.19 Million	0.197x	-10.44%
2006-12-31	€40.13 Million ≈ $46.92 Million	€8.83 Million ≈ $10.32 Million	0.220x	+430.06%
2005-12-31	€31.52 Million ≈ $36.85 Million	€1.31 Million ≈ $1.53 Million	0.041x	-73.32%
2004-12-31	€15.47 Million ≈ $18.08 Million	€2.41 Million ≈ $2.81 Million	0.156x	+384.79%
2003-12-31	€12.87 Million ≈ $15.05 Million	€413.00K ≈ $482.84K	0.032x	-99.98%
2002-12-31	€11.17K ≈ $13.06K	€1.73 Million ≈ $2.03 Million	155.162x	--

About Stratec SE

XETRA:SBS Germany Medical Devices

Market Cap

$250.12 Million

€213.94 Million EUR

Market Cap Rank

#15820 Global

#1516 in Germany

Share Price

€17.60

Change (1 day)

-0.11%

52-Week Range

€16.86 - €32.00

All Time High

€139.81